+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bioinformatics Market By Product And Services, By Applications - Growth, Share, Opportunities & Competitive Analysis, 2020 - 2028

  • ID: 5148429
  • Report
  • September 2020
  • Region: Global
  • 102 pages
  • Acute Market Reports
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 3rd Millennium Inc.
  • Affymetrix
  • Agilent Technologies
  • BIOVIA (Accelrys Inc.)
  • Celera Corporation
  • IBM Life Sciences
  • MORE
The report titled “Bioinformatics Market- Growth, Future Prospects, and Competitive Analysis, 2020 – 2028” offers strategic insights into the overall bioinformatics market along with the market size and estimates for the duration 2018 to 2028. The said research study covers in-depth analysis of multiple market segments based on types of products & services, applications, and different geographies. Bioinformatics helps to carry out processes such as recovery, storage, processing, management, and analysis of organic information through statistical techniques coupled with modern information and technology base. In the modern world of drug innovation and development, bioinformatics plays a key role in data storage, data recovery, data analysis, and efficient management of biological information to study the process of drug development. The global bioinformatics market was segmented on the basis of applications, products and services, and regions. On the basis of products & services, the bioinformatics market was further segmented as bioinformatics platforms, bio content management tools, and bioinformatics services. The application segmented was further bifurcated into genomics, molecular phylogenetics, metabolomics, transcriptomics, proteomics, chemoinformatics & drug designing, and others.

For the purpose of this study, the global bioinformatics market on the basis of products & services is segmented into bioinformatics platforms, bio content management tools, and bioinformatics services. Market size estimates and forecast for these segments for the period 2018 to 2028 are provided in terms of US$ Mn along with the respective compounded annual growth rates (CAGRs) for the period 2020 to 2028, considering 2019 as the base year.

On the basis of application type global bioinformatics market is segmented as genomics, molecular phylogenetics, metabolomics, transcriptomics, proteomics, chemoinformatics & drug designing, and others. Market size estimates and forecast for these segments for the period 2018 to 2028 are provided in terms of US$ Mn along with the respective compounded annual growth rates (CAGRs) for the period 2020 to 2028, considering 2019 as the base year.

The bioinformatics market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments from 2018 to 2028 and their CAGRs for the period 2020 to 2028 are provided in this report.

The bioinformatics market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are BIOVIA (Accelrys Inc.), IBM Life Sciences, 3rd Millennium Inc., Life Technologies Corporation, Rosetta Biosoftware, Agilent Technologies, Affymetrix, Inc., Celera Corporation, and others.

Based on the type of products & services, the global bioinformatics market is segmented as follows:
  • Bio content Management Tools
  • Bioinformatics Platforms
  • Bioinformatics Services
In 2019, the bio content management tools segment was observed as the largest products & services segment, accounting for 40% of the overall market. The key factors assisting the market are the growing application rate of bioinformatics tools and software in database management. During the forecast period 2020 – 2028, bioinformatics platforms are expected to grow significantly due to the increasing demand for sequence analysis platforms and other biotechnology applications. In addition, the growth of the bioinformatics platform is due to the reduced turnaround time for data processing, identification of sequence match, and phylogenetic analysis. The market experts suggested that there are several opportunities for bioinformatics in upcoming technologies such as nanopore-sequencing and cloud computing. For efficiently managing huge databases related to drug innovation and development bioinformatics assists in storing, retrieving, analyzing and formation of collective information.

Based on the type of application, the global bioinformatics market is segmented as follows:
  • Genomics
  • Molecular Phylogenetics
  • Metabolomics
  • Transcriptomics
  • Proteomics
  • Chemoinformatics & Drug Designing
  • Others
Bioinformatics has a wide range of several applications; in the year 2019 genomics dominated the market with over 24% share due to the rising need for pharmacogenomics in the process of drug development and gene sequencing. It was observed that in the field of bioinformatics introduction of technological advancements was largely carried out focusing management of large datasets involved in genomics. During the forecast period 2020 – 2028, the chemoinformatics & drug designing segment was expected to grow at a significant growth rate due to rising demand in biomarker discovery and development. In the latter stages of clinical trials majority of the drugs fail which leads to a huge loss of investments; however, after post introduction of bioinformatics the R&D expenditure rate has been reduced and has also helped to reduce clinical trial failure to a noticeable extent.

For the purpose of this study, the global bioinformatics market is categorized into:
  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)
In the base year 2019, North America accounted for over 40% and expected to retain its dominance throughout the forecast period. The key factors assisting the growth of the North American market are the availability of accessible and advanced healthcare infrastructure coupled with the presence of technologically advanced IT companies. North America records the world’s highest number of clinical trials and research and development which generates a huge amount of database. Europe is the second-largest bioinformatics market and its growth is assisted due to the existence of technologically advanced healthcare infrastructure and research facilities coupled with huge research and development activities carried out by leading pharmaceutical and biotechnology companies. During the forecast period 2020 - 2028, Asia Pacific is expected to witness significant growth due to factors such as growing demand for clinical research outsourcing in the emerging markets of India and China, developing healthcare and research infrastructure, and it’s a base of several established and budding IT companies.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 3rd Millennium Inc.
  • Affymetrix
  • Agilent Technologies
  • BIOVIA (Accelrys Inc.)
  • Celera Corporation
  • IBM Life Sciences
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Bioinformatics Market Portraiture
2.2 Global Bioinformatics Market, by Products & Services, 2019 Vs 2028 (Value %)
2.3 Global Bioinformatics Market, by Application, 2019 Vs 2028 (Value %)
2.4 Global Bioinformatics Market, by Geography, 2019 Vs 2028 (Value %)

Chapter 3 Bioinformatics Market Analysis
3.1 Global Bioinformatics Market Analysis
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Increasing demand for data management services and products in the healthcare R&D industry
3.2.1.2 Rising application of proteomics and genomics in the development of effective therapeutics
3.2.1.3 Increasing number of collaborations in pharmaceutical companies and research and development institutes or universities
3.2.2 Challenges
3.2.2.1 Data Integration is difficult due to the lack of uniform standards and common data formats
3.2.3 Opportunities
3.2.3.1 Rising demand for Nanopore Sequencing Technology and Cloud Technology in the near future
3.2.3.1 Developing healthcare infrastructure in emerging economies such as Brazil, India, and China will Boost the Market Growth
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Vendors in Bioinformatics Market.

Chapter 4 Global Bioinformatics Market Analysis, by Type of Products & Services
4.1 Introduction
4.2 Bio content Management Tools
4.3 Bioinformatics Platforms
4.4 Bioinformatics Services

Chapter 5 Global Bioinformatics Market, By Applications
5.1 Introduction
5.2 Genomics
5.3 Molecular Phylogenetics
5.4 Metabolomics
5.5 Transcriptomics
5.6 Proteomics
5.7 Chemoinformatics & Drug Designing
5.8 Others

Chapter 6 Global Bioinformatics Market, By Geography
6.1 Preface
6.2 North America
6.2.1 U.S
6.2.2 Canada
6.3 Europe
6.2.1 U.K
6.2.2 Germany
6.2.1 Rest of Europe
6.4 Asia Pacific
6.2.1 China
6.2.2 Japan
6.2.1 Rest of Asia Pacific
6.5 Latin America
6.6 Middle East and Africa

Chapter 7 Company Profiles
7.1 BIOVIA (Accelrys Inc.)
7.1.1 BIOVIA (Accelrys Inc.): Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
7.2 IBM Life Sciences
7.2.1 IBM Life Sciences: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
7.3 3rd Millennium Inc.
7.3.1 3rd Millennium Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
7.4 Life Technologies Corporation
7.4.1 Life Technologies Corporation: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
7.5 Agilent Technologies
7.5.1 Agilent Technologies: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
7.6 Affymetrix
7.6.1 Affymetrix: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
7.7 Celera Corporation
7.7.1 Celera Corporation: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
7.8 Rosetta Biosoftware
7.8.1 Rosetta Biosoftware: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
7.9 BioWisdom Ltd. (Instem)
7.9.1 BioWisdom Ltd. (Instem): Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 3
  • BIOVIA (Accelrys Inc.)
  • IBM Life Sciences
  • 3rd Millennium Inc.
  • Life Technologies Corporation
  • Agilent Technologies
  • Affymetrix
  • Celera Corporation
  • Rosetta Biosoftware
Note: Product cover images may vary from those shown
Adroll
adroll